One for All and All for One: The Triumph of the One Study

Transplantation. 2021 Feb 1;105(2):273-274. doi: 10.1097/TP.0000000000003474.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adoptive Transfer* / adverse effects
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control*
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation* / adverse effects
  • Monitoring, Immunologic
  • Non-Randomized Controlled Trials as Topic
  • Transplantation Tolerance*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents